首页> 美国卫生研究院文献>Health Services Research and Managerial Epidemiology >A Higher Number of Covid19 Cases and Fatalities in Israel Phased With the Start of the Mass Vaccination
【2h】

A Higher Number of Covid19 Cases and Fatalities in Israel Phased With the Start of the Mass Vaccination

机译:以色列的较数较多的Covid19病例和以色列的死亡率随着大规模疫苗接种的开始阶段

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The manuscript proposes the major parameters needed to monitor the Israeli Covid19 outbreak. According to,1 these are the number of infected, tested, and the share of the positive tests, recovered, succumbed. Additionally, it is also proposed the number of vaccine doses administered, the share of the population who received at least 1 vaccine dose, and the share of the population fully vaccinated. While it would be necessary to also have a breakdown of the parameters in the partially and fully vaccinated and the control group, and a further subdivision for age and comorbidities, these data are missing. It is shown as the number of Covid19 cases and fatalities in Israel have increased phased with the start of the mass vaccination, and they have also been higher than in neighboring countries.
机译:稿件提出了监控以色列Covid19爆发所需的主要参数。根据,其中1个是受感染,测试的数量和阳性测试的份额,恢复,持续。此外,还提出了施用的疫苗剂量的数量,接受至少1个疫苗剂量的群体的份额以及完全接种疫苗的人口的份额。虽然有必要在部分和完全接种的接种和对照组中具有参数的崩溃,以及用于年龄和合并症的进一步细分,这些数据缺失。它显示为Covid19案例的数量,以色列的死亡率随着大规模疫苗接种的开始而增加,它们也高于邻国。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号